Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

418 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reply by Authors.
Farolfi A, Gafita A, Calais J, Eiber M, Afshar-Oromieh A, Spohn F, Barbato F, Weber M, Ilhan H, Cervati V, Wetter A, Hadaschik B, Briganti A, Walz J, Pianori D, Fanti S, Haberkorn U, Herrmann K, Fendler WP. Farolfi A, et al. Among authors: hadaschik b. J Urol. 2019 Dec;202(6):1181. doi: 10.1097/01.JU.0000582680.86998.12. Epub 2019 Sep 16. J Urol. 2019. PMID: 31524577 No abstract available.
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.
Afshar-Oromieh A, Malcher A, Eder M, Eisenhut M, Linhart HG, Hadaschik BA, Holland-Letz T, Giesel FL, Kratochwil C, Haufe S, Haberkorn U, Zechmann CM. Afshar-Oromieh A, et al. Among authors: hadaschik ba. Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):486-95. doi: 10.1007/s00259-012-2298-2. Epub 2012 Nov 24. Eur J Nucl Med Mol Imaging. 2013. PMID: 23179945
Reply to Reske et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.
Afshar-Oromieh A, Malcher A, Eder M, Eisenhut M, Linhart HG, Hadaschik BA, Holland-Letz T, Giesel FL, Kratochwil C, Haufe S, Haberkorn U, Zechmann CM. Afshar-Oromieh A, et al. Among authors: hadaschik ba. Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):971-2. doi: 10.1007/s00259-013-2386-y. Epub 2013 Apr 5. Eur J Nucl Med Mol Imaging. 2013. PMID: 23558688 No abstract available.
Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru TH, Roethke MC, Seidenader J, Simpfendörfer T, Boxler S, Alammar K, Rieker P, Popeneciu VI, Roth W, Pahernik S, Schlemmer HP, Hohenfellner M, Hadaschik BA. Kuru TH, et al. J Urol. 2013 Oct;190(4):1380-6. doi: 10.1016/j.juro.2013.04.043. Epub 2013 Apr 19. J Urol. 2013. PMID: 23608676 Clinical Trial.
PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancer.
Afshar-Oromieh A, Haberkorn U, Hadaschik B, Habl G, Eder M, Eisenhut M, Schlemmer HP, Roethke MC. Afshar-Oromieh A, et al. Among authors: hadaschik b. Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1629-30. doi: 10.1007/s00259-013-2489-5. Epub 2013 Jul 2. Eur J Nucl Med Mol Imaging. 2013. PMID: 23817686 No abstract available.
Editorial comment.
Kuru TH, Hadaschik BA. Kuru TH, et al. J Urol. 2013 Dec;190(6):2025. doi: 10.1016/j.juro.2013.05.129. Epub 2013 Sep 16. J Urol. 2013. PMID: 24050904 No abstract available.
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.
Afshar-Oromieh A, Zechmann CM, Malcher A, Eder M, Eisenhut M, Linhart HG, Holland-Letz T, Hadaschik BA, Giesel FL, Debus J, Haberkorn U. Afshar-Oromieh A, et al. Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):11-20. doi: 10.1007/s00259-013-2525-5. Epub 2013 Sep 27. Eur J Nucl Med Mol Imaging. 2014. PMID: 24072344 Free PMC article.
418 results